Heimo Nurmi

1.2k total citations
14 papers, 886 citations indexed

About

Heimo Nurmi is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Heimo Nurmi has authored 14 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Genetics. Recurrent topics in Heimo Nurmi's work include Liver Disease Diagnosis and Treatment (6 papers), Microscopic Colitis (5 papers) and Liver Diseases and Immunity (5 papers). Heimo Nurmi is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Microscopic Colitis (5 papers) and Liver Diseases and Immunity (5 papers). Heimo Nurmi collaborates with scholars based in Finland, United States and Norway. Heimo Nurmi's co-authors include Martti Färkkilâ, Päivi Kärkkäinen, Pekka Pikkarainen, Hannu Nuutinen, Henna Rautiainen, Anna–Liisa Karvonen, A.-L. Karvonen, Matti Ristikankare, Veli‐Jukka Anttila and Eero Mattila and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Heimo Nurmi

14 papers receiving 870 citations

Peers

Heimo Nurmi

EPIDE

HEPAT

SURGE

Damien Lucidarme France

Leonieke M. M. Wolters Netherlands

G. Choudhuri India

James M. Gulizia United States

Fuad Hasan Kuwait

Vedat Göral Türkiye

Emil Miskovsky United States

Roberta Pica Italy

Órla Crosbie Ireland

H Thompson United Kingdom

Damien Lucidarme France

Heimo Nurmi

597 ×1.2

EPIDE

356 ×1.0

HEPAT

309 ×0.9

SURGE

76 ×0.3

75 ×0.4

Citations per year, relative to Heimo Nurmi Heimo Nurmi (= 1×) peers Damien Lucidarme

Countries citing papers authored by Heimo Nurmi

Since Specialization

Citations

This map shows the geographic impact of Heimo Nurmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heimo Nurmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heimo Nurmi more than expected).

Fields of papers citing papers by Heimo Nurmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heimo Nurmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heimo Nurmi. The network helps show where Heimo Nurmi may publish in the future.

Co-authorship network of co-authors of Heimo Nurmi

This figure shows the co-authorship network connecting the top 25 collaborators of Heimo Nurmi. A scholar is included among the top collaborators of Heimo Nurmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heimo Nurmi. Heimo Nurmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Roivainen, Anne, Rauli Leino, Heimo Nurmi, et al.. (2013). Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate. EJNMMI Research. 3(1). 13–13. 7 indexed citations

Mattila, Eero, Raija Uusitalo‐Seppälä, Maarit Wuorela, et al.. (2011). Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection. Gastroenterology. 142(3). 490–496. 282 indexed citations

Färkkilâ, Martti, Henna Rautiainen, Päivi Kärkkäinen, et al.. (2008). Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Liver International. 28(6). 787–797. 23 indexed citations

Rautiainen, Henna, Veikko Salomaa, Seppo Niemelä, et al.. (2007). Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scandinavian Journal of Gastroenterology. 42(11). 1347–1353. 47 indexed citations

Rautiainen, Henna, Martti Färkkilâ, Mikko Neuvonen, et al.. (2006). Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis. Alimentary Pharmacology & Therapeutics. 24(11-12). 1545–1552. 15 indexed citations

Haapamäki, Markku M., Juha Grönroos, Heimo Nurmi, et al.. (2006). Value of blood tests including serum group IIA phospholipase A₂and bactericidal/permeability‐increasing protein in Crohn's disease. Scandinavian Journal of Clinical and Laboratory Investigation. 66(7). 585–594. 4 indexed citations

Rautiainen, Henna, Päivi Kärkkäinen, A.-L. Karvonen, et al.. (2005). Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis. Hepatology. 41(4). 747–752. 156 indexed citations

Färkkilâ, Martti, Anna–Liisa Karvonen, Heimo Nurmi, et al.. (2004). Metronidazole and Ursodeoxycholic Acid for Primary Sclerosing Cholangitis: A Randomized Placebo–Controlled Trial. Hepatology. 40(6). 1379–1386. 157 indexed citations

Färkkilâ, Martti, Päivi Kärkkäinen, Anna–Liisa Karvonen, et al.. (2003). Combination of ursodeoxycholic acid (UDCA) and metronidazole (MTZ) in PSC: Reduction of inflammation in liver correlates with the decrease of the New Mayo Risk Score. Gastroenterology. 124(4). A707–A707. 1 indexed citations

10.

Paavola, Paulina, Tiina Heliö, Maija Kiuru, et al.. (2001). Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21. European Journal of Human Genetics. 9(5). 328–334. 36 indexed citations

11.

Haapamäki, Markku M., Juha Grönroos, Heimo Nurmi, Kalle Alanen, & Timo J. Nevalainen. (1999). Gene Expression of Group Ii Phospholipase A2 in Intestine in Crohn's Disease. The American Journal of Gastroenterology. 94(3). 713–720. 40 indexed citations

12.

Haapamäki, Markku M., et al.. (1998). Elevated Group 11 Phospholipase A₂ Mass Concentration in Serum and Colonic Mucosa in Crohn's Disease. Clinical Chemistry and Laboratory Medicine (CCLM). 36(10). 751–755. 19 indexed citations

13.

Haapamäki, Markku M., Juha Grönroos, Heimo Nurmi, et al.. (1997). Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.. Gut. 40(1). 95–101. 66 indexed citations

14.

Tarpila, S, Ulla Turunen, K. Seppälä, et al.. (1994). Budesonide enema active haemorrhagic proctitis—a controlled trial against hydrocortisone foam enema. Alimentary Pharmacology & Therapeutics. 8(6). 591–595. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact